Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Market Cap	1.19B
Revenue (ttm)	644.82M
Net Income (ttm)	62.40M
Shares Out	562.11M
EPS (ttm)	0.11
PE Ratio	19.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,125,280
Average Volume	2,919,084
Open	2.090
Previous Close	2.090
Day's Range	2.100 - 2.130
52-Week Range	1.580 - 2.700
Beta	0.01
RSI	48.13
Earnings Date	Aug 25, 2025

About EGX:MCRO

Macro Group Pharmaceuticals (Macro Capital) S.A.E operates as a cosmeceuticals manufacturing company in Egypt and internationally. It engages in the production of pharmaceutical and cosmetic products, such as skin care, hair care, oral care, female intimate care, anti-scar, antiseptics, and topical muscle relaxants, as well as flavors, colors, and scents. The company also manufactures solid and liquid soap, herbal medicines, products and extracts, nutritional supplements, baby food, and special food products. It also offers its products online....

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2002
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MCRO

Financial Performance

In 2024, EGX:MCRO's revenue was 519.97 million, a decrease of -1.15% compared to the previous year's 526.01 million. Losses were -38.10 million, -86.03% less than in 2023.